Canadian Solar Inc. (NASDAQ:CSIQ): Northland Securities raised Canadian Solar’s price target to $40 from $26 following the third-quarter report that cited strong execution, sustainable earnings, and cash generation. The analyst rates the shares an Outperform.
Finish Line Inc. (NASDAQ:FINL): B. Riley upgraded Finish Line to Buy from Neutral; the firm upgraded shares noting favorable channel checks, new product momentum, and easier comps. The analyst raised its price target on the shares to $32 from $26.
Citrix Systems, Inc. (NASDAQ:CTXS): Stifel believes that Amazon.com, Inc.’s (NASDAQ:AMZN): new Desktop-as-a-Service offering, WorkSpaces, will primarily appeal to the low end of the market, and is unlikely to impact Citrix’s business in the near to medium term. The firm keeps a $70 price target and a Buy rating on Citrix.
Pharmacyclics, Inc. (NASDAQ:PCYC): Wedbush removed Pharmacyclics from the Best Ideas List following IMBRUVICA approval for Mantle Cell Lymphoma. The firm sees high off-label expectations and temporary patient access headwinds as limiting the shares in the near-term. The analyst continues to rates shares an Outperform and maintains a $165 price target.